An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
Bristol-Myers Squibb
Bristol-Myers Squibb
University of Washington
OHSU Knight Cancer Institute
Amgen
Barbara Ann Karmanos Cancer Institute